Amy Cyr

4.3k total citations
46 papers, 607 citations indexed

About

Amy Cyr is a scholar working on Cancer Research, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Amy Cyr has authored 46 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cancer Research, 21 papers in Pathology and Forensic Medicine and 20 papers in Surgery. Recurrent topics in Amy Cyr's work include Breast Cancer Treatment Studies (38 papers), Breast Lesions and Carcinomas (21 papers) and Breast Implant and Reconstruction (18 papers). Amy Cyr is often cited by papers focused on Breast Cancer Treatment Studies (38 papers), Breast Lesions and Carcinomas (21 papers) and Breast Implant and Reconstruction (18 papers). Amy Cyr collaborates with scholars based in United States, Nigeria and Australia. Amy Cyr's co-authors include Julie A. Margenthaler, William E. Gillanders, Rebecca Aft, Feng Gao, Timothy J. Eberlein, Foluso O. Ademuyiwa, Catherine M. Appleton, Terence M. Myckatyn, Marissa M. Tenenbaum and Imran Zoberi and has published in prestigious journals such as PLoS ONE, Cancer Research and Annals of Surgery.

In The Last Decade

Amy Cyr

43 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Cyr United States 16 420 281 246 178 98 46 607
Emilia Dauway United States 10 562 1.3× 466 1.7× 246 1.0× 178 1.0× 106 1.1× 18 725
Monique Cohen France 16 547 1.3× 267 1.0× 363 1.5× 266 1.5× 52 0.5× 72 729
Barbara Fowble United States 6 643 1.5× 476 1.7× 305 1.2× 233 1.3× 111 1.1× 10 756
M. Del Vecchio Italy 6 545 1.3× 340 1.2× 237 1.0× 271 1.5× 59 0.6× 12 713
Cristina Olcese United States 11 316 0.8× 236 0.8× 123 0.5× 148 0.8× 75 0.8× 17 437
F. O’Malley Canada 6 332 0.8× 209 0.7× 136 0.6× 223 1.3× 90 0.9× 9 476
M.F. Ernst Netherlands 15 407 1.0× 243 0.9× 190 0.8× 392 2.2× 57 0.6× 28 664
A. Helen Westenberg Netherlands 11 334 0.8× 189 0.7× 179 0.7× 220 1.2× 59 0.6× 19 520
Victor J. Zannis United States 13 567 1.4× 302 1.1× 251 1.0× 139 0.8× 107 1.1× 18 662
F. Laki France 14 475 1.1× 278 1.0× 182 0.7× 216 1.2× 90 0.9× 40 658

Countries citing papers authored by Amy Cyr

Since Specialization
Citations

This map shows the geographic impact of Amy Cyr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Cyr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Cyr more than expected).

Fields of papers citing papers by Amy Cyr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Cyr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Cyr. The network helps show where Amy Cyr may publish in the future.

Co-authorship network of co-authors of Amy Cyr

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Cyr. A scholar is included among the top collaborators of Amy Cyr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Cyr. Amy Cyr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Cyr, Amy, et al.. (2023). Individualizing Breast Cancer Risk Assessment in Clinical Practice. Surgical Oncology Clinics of North America. 32(4). 647–661. 3 indexed citations
3.
Politi, Mary C., Catherine Saunders, Renata W. Yen, et al.. (2021). An absence of equipoise: Examining surgeons’ decision talk during encounters with women considering breast cancer surgery. PLoS ONE. 16(12). e0260704–e0260704. 2 indexed citations
4.
Kennedy, William R., Jennifer Stanley, Jingqin Luo, et al.. (2020). Single-Institution Phase 1/2 Prospective Clinical Trial of Single-Fraction, High-Gradient Adjuvant Partial-Breast Irradiation for Hormone Sensitive Stage 0-I Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 107(2). 344–352. 16 indexed citations
5.
Margenthaler, Julie A., et al.. (2020). Oncologic Safety and Outcomes in Patients Undergoing Nipple-Sparing Mastectomy. Journal of the American College of Surgeons. 230(4). 535–541. 29 indexed citations
6.
Cyr, Amy. (2020). Genetic Testing is Not “One and Done”. Annals of Surgical Oncology. 27(7). 2114–2116. 1 indexed citations
7.
Kennedy, William R., Michael Roach, Laura Ochoa‐Callejero, et al.. (2019). Long-Term Outcomes with 3-Dimensional Conformal External Beam Accelerated Partial Breast Irradiation. Practical Radiation Oncology. 10(3). e128–e135. 4 indexed citations
8.
Gabani, Prashant, Amy Cyr, Julie A. Margenthaler, et al.. (2017). Long-term outcomes of APBI via multicatheter interstitial HDR brachytherapy: Results of a prospective single-institutional registry. Brachytherapy. 17(1). 171–180. 14 indexed citations
9.
Myckatyn, Terence M., et al.. (2017). Nipple-sparing mastectomies: Clinical outcomes from a single academic institution. Molecular and Clinical Oncology. 6(5). 737–742. 13 indexed citations
10.
Cyr, Amy, Foluso O. Ademuyiwa, Adel Tabchy, et al.. (2016). Axillary Ultrasound Accurately Excludes Clinically Significant Lymph Node Disease in Patients With Early Stage Breast Cancer. Annals of Surgery. 264(6). 1098–1102. 48 indexed citations
11.
Rehman, Sana, Pippa F. Cosper, Amy Cyr, et al.. (2016). Prospective analysis of toxicity in patients treated with strut-adjusted volume implant for early-stage breast cancer. Brachytherapy. 15(5). 625–630. 9 indexed citations
12.
Ademuyiwa, Foluso O., Amy Cyr, Jennifer Ivanovich, & Maria Thomas. (2015). Managing breast cancer in younger women: challenges and solutions. Breast Cancer Targets and Therapy. 8. 1–1. 31 indexed citations
13.
Margenthaler, Julie A., et al.. (2015). Staging studies have limited utility for newly diagnosed stage I–II breast cancer. Journal of Surgical Research. 196(1). 33–38. 15 indexed citations
14.
Yan, Yan, et al.. (2015). Predictors of false negative axillary ultrasound in breast cancer. Journal of Surgical Research. 198(2). 351–354. 12 indexed citations
15.
Margenthaler, Julie A., Frank E. Johnson, & Amy Cyr. (2013). Intensity of Follow-Up After Breast Cancer Surgery: Low Versus High?. Annals of Surgical Oncology. 21(3). 733–737. 4 indexed citations
16.
Yu, Jennifer S., Marie E. Taylor, Amy Cyr, et al.. (2012). Compromised margins following mastectomy for stage I–III invasive breast cancer. Journal of Surgical Research. 177(1). 102–108. 12 indexed citations
17.
Fisher, Carla S., et al.. (2011). Ultrasound-Guided Lumpectomy for Palpable Breast Cancers. Annals of Surgical Oncology. 18(11). 3198–3203. 24 indexed citations
18.
Cyr, Amy, Julie A. Margenthaler, Antonella Rastelli, et al.. (2011). Correlation of Ductal Lavage Cytology with Ductoscopy-Directed Duct Excision Histology in Women at High Risk for Developing Breast Cancer: A Prospective, Single-Institution Trial. Annals of Surgical Oncology. 18(11). 3192–3197. 8 indexed citations
19.
Cyr, Amy, William E. Gillanders, Rebecca Aft, Timothy J. Eberlein, & Julie A. Margenthaler. (2010). Breast cancer in elderly women (≥80 years): variation in standard of care?. Journal of Surgical Oncology. 103(3). 201–206. 35 indexed citations
20.
Cyr, Amy, Deborah V. Novack, Kathryn Trinkaus, et al.. (2010). Are We Overtreating Papillomas Diagnosed on Core Needle Biopsy?. Annals of Surgical Oncology. 18(4). 946–951. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026